The breast lesion localization devices market is showing consistent expansion, with an estimated compound annual growth rate of approximately 7% over the forecast period. This growth is fueled by the ...
A new study led by researchers at Wake Forest University School of Medicine and Atrium Health Levine Cancer has found that a ...
Milan, Italy – September 5, 2025 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™ (EU) / SOFTAG™ (U.S.) bioresorbable scaffolds for breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results